GENX Stock Overview
Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Genex Pharmaceutical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.0001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | -98.39% |
| 5 Year Change | -98.89% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| GENX | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -2.9% | -3.2% |
| 1Y | 0% | -3.7% | 19.3% |
Return vs Industry: GENX exceeded the US Medical Equipment industry which returned -1.8% over the past year.
Return vs Market: GENX underperformed the US Market which returned 15.2% over the past year.
Price Volatility
| GENX volatility | |
|---|---|
| GENX Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: GENX has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GENX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | Fuzhi Song | n/a |
Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People’s Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers.
Genex Pharmaceutical, Inc. Fundamentals Summary
| GENX fundamental statistics | |
|---|---|
| Market cap | US$1.78k |
| Earnings (TTM) | US$342.55k |
| Revenue (TTM) | US$3.24m |
0.0x
P/E Ratio0.0x
P/S RatioIs GENX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GENX income statement (TTM) | |
|---|---|
| Revenue | US$3.24m |
| Cost of Revenue | US$362.72k |
| Gross Profit | US$2.87m |
| Other Expenses | US$2.53m |
| Earnings | US$342.55k |
Last Reported Earnings
Dec 31, 2007
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did GENX perform over the long term?
See historical performance and comparison